Wistar Institute

Wistar Institute. Founded in 1892 through a bequest from philanthropist Isaac J. Wistar, it is the oldest independent nonprofit biomedical research institution in the United States. Located in the University City section of Philadelphia, it has maintained a historic affiliation with the University of Pennsylvania. The institute is dedicated exclusively to basic and translational research in cancer, immunology, and infectious disease.

History

The institute was established as a legacy of Isaac J. Wistar, a prominent Philadelphia lawyer and former Brigadier General in the Union Army. Its original mission, guided by early leaders like anatomist Milton J. Greenman, was as a museum of anatomy and biology and a center for anatomical research. A pivotal shift occurred in 1906 with the appointment of Henry H. Donaldson and the subsequent hiring of Helen Dean King, a pioneering geneticist who conducted foundational work with the Wistar rat. Under the directorship of Edmund B. Wilson and later M. R. Curtis, the institute evolved from a museum into a premier research hub, formally severing its museum functions in the mid-20th century. Its modern research identity was cemented under the leadership of Hilary Koprowski, who served as director from 1957 to 1991 and oversaw the development of the rabies vaccine and other major virology programs.

Research programs

Research is organized into multidisciplinary programs focusing on cancer biology, immunology, and virology. The Cancer Center at the institute, a National Cancer Institute-designated basic research cancer center, investigates mechanisms of tumorigenesis, metastasis, and therapeutic resistance. The Immunology, Microenvironment & Metastasis Program explores interactions between the immune system and cancer cells, including the role of the tumor microenvironment. The Gene Expression and Regulation Program studies epigenetics, non-coding RNA, and genome instability. In infectious disease, scientists study pathogens like HIV, Zika virus, and influenza, with a strong emphasis on vaccine and therapeutic development, continuing a legacy from the work of Hilary Koprowski and others on the oral polio vaccine.

Scientific achievements

The institute is renowned for seminal contributions to biomedical science. It developed the Wistar rat, the first standardized laboratory rat strain, which became a cornerstone of biomedical research globally. In virology, researchers led by Hilary Koprowski created the first successful oral polio vaccine and a widely used rabies vaccine. Scientists at the institute discovered the Philadelphia chromosome, the first consistent genetic abnormality linked to a human cancer, specifically chronic myelogenous leukemia. More recent breakthroughs include pioneering work on telomerase and its role in cancer, fundamental discoveries in p53 tumor suppressor biology, and the development of novel monoclonal antibody therapies and cancer vaccine platforms.

Leadership and organization

The institute is led by a president and director, a role held since 2015 by cancer biologist Dario C. Altieri. Governance is provided by a Board of Trustees composed of scientific, business, and community leaders. Scientific direction is further shaped by an external Scientific Advisory Board comprising eminent researchers from institutions like the National Institutes of Health and Massachusetts Institute of Technology. The institute operates with a flexible, collaborative structure devoid of traditional academic departments, fostering interdisciplinary work among its approximately 40 principal investigators. It maintains a close alliance with the University of Pennsylvania and clinical partners like the Abramson Cancer Center, facilitating rapid translation of discoveries.

Facilities and resources

The institute's main facility is a modern, purpose-built research complex on a campus shared with the University of Pennsylvania and Children's Hospital of Philadelphia. It houses state-of-the-art core facilities including the Molecular Screening Facility, the Biomedical Research Support Facility, and the Genomics Facility. These shared resources provide advanced technologies in bioinformatics, cryo-electron microscopy, and high-throughput sequencing. The institute also operates robust technology transfer and business development offices to manage its intellectual property portfolio and foster partnerships with the pharmaceutical industry, supporting the commercialization of discoveries. Category:Biomedical research institutes in the United States Category:Organizations based in Philadelphia Category:1892 establishments in Pennsylvania